|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/496 | |
| A61P 37/00 |
| (11) | Patento numeris | 3028702 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16153335.1 |
| Europos patento paraiškos padavimo data | 2011-11-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-06-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-09-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 416689 P | 2010-11-23 | US |
| (72) |
ELMORE, Steven, US
SOUERS, Andrew, US
WANG, Li Chun, US
GHAYUR, Tariq, US
PERPER, Stuart J., US
|
| (73) |
AbbVie Ireland Unlimited Company,
70 Sir John Rogerson`s Quay, Dublin 2,
IE
|
| (54) | METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS |
| METHODS OF TREATMENT USING SELECTIVE BCL-2 INHIBITORS |